You share time or records.
For patients
Your participation can help create value. Any sharing happens only under program rules.
Mito Discovery Alliance is built around a simple fairness principle: patients should know what they are joining before they share information. Participation may create future value, but any sharing of that value depends on approved program rules, qualifying revenue, and review. The same published rules apply to everyone in a program, so people can compare opportunities before they decide.
Every additional participant can make the program more useful for natural history research, study design, recruitment, and future treatment development.
Today
Many programs make the rules hard to see up front.
You complete surveys or check-ins.
You join studies when you want to.
You may use devices or apps.
The work can help sponsors, researchers, or companies.
You should be able to see the rules before you decide.
Mito Discovery Alliance changes that.
You own your participation.
You choose what to share, review opportunities before joining, and can be compensated when programs qualify. Your data can help researchers understand disease patterns, prepare studies, and plan future work. If an approved program creates qualifying value, the published rules explain how any patient sharing is handled.
You choose what to share
Participation is consent-driven, opportunity by opportunity. You can say yes, no, or wait.
You can be compensated
Some activities or approved program results may create patient compensation opportunities. No payment is guaranteed.
Your data helps research
Better participation helps researchers understand disease, prepare studies, and review what questions are worth asking next.
Value can flow back
If an approved program creates qualifying value, some of that value may be shared with the patients who helped create it, subject to program rules and eligibility.
How participation is recognized
Contribution credits can reflect data completeness, data freshness, verification, longitudinal participation, research responses, wearable summaries, and functional testing summaries. They help document participation activity; they are not cash, equity, tokens, or a guaranteed payment.
Higher participation levels require more than signing up: dated Mito Map or equivalent evidence, diagnostic or genetics status where available, recent clinical and lab summaries, repeated longitudinal updates, and measured functional testing or clinician-assessed function when feasible. The published rules stay the same for every member in a program so crediting is visible and comparable.
What "program credit pool" means
The program credit pool is a program-wide planning number based on the expected participant count and the listed participation tasks. It is not a per-person grant. Individual members earn contribution credits only for completed, consented, and recorded participation activity.
Why goals are higher than expected active counts
Some members may sign up but not complete baseline evidence, consent steps, record sync, or repeat follow-up. The expected active count is an estimate of the cohort likely to remain engaged for natural history, research, and recruitment conversations.
How credits are given out
Credits are recorded after an activity is completed or validated: Mito Map summary sync, equivalent structured evidence review, diagnostic or genetics validation where applicable, longitudinal check-ins, measured function or wearable summaries, accepted research opportunities, and invited advisory or review work.
Open research opportunities list a specific credit amount. Those opportunity credits are added when a member opts in and are removed if the member later declines or withdraws. Task credits require the underlying evidence to stay complete, current, and consistent with the opportunity requirements.
How distributions may work
Patient Success Distributions may occur only if qualifying commercial revenue exists and the program approves a distribution under governing rules. The current v1 engine treats eligible members as active enrolled program members with at least 50 recorded participation credits, then allocates approved direct-patient pool amounts pro-rata by qualifying credits. If payments are approved, they are recorded in member ledgers. No payment is guaranteed.
Available aggregate direct-patient balance
Across recorded pool events
Revenue events contributing to pools
Approved aggregate total
How qualifying revenue is split
When revenue qualifies, MDA records a direct patient pool, patient-services support, research reinvestment, and platform reinvestment. The current default split of allocated qualifying revenue is 35% direct patient pool, 20% patient services, 25% research reinvestment, and 20% platform reinvestment.
Researcher value sharing
The Alliance can also track a separate Researcher Value Pool for researchers who publish with consented Alliance data. This is meant to reward useful, compliant publication work without taking value away from patient participation recognition. Researcher awards depend on publication status, program approval, available qualifying value, and applicable rules.
Public participant dashboard
Open registry participation metrics.
This dashboard shows aggregate Alliance participation without exposing member identities or private health data. Source labels below explain whether a number is Observed, Synced summary, Derived, or Planning.
Observed aggregate count
Synced summary count
Observed Alliance program count
Observed open request count
Derived from latest contribution scores
Derived Research Asset Index across programs
Derived from synced summaries
Observed recent-update count
No public member identifiers
How to read this page
We would rather label a number carefully than make it sound more certain than it is.
Observed means a count comes from current Alliance records. Synced summary means the number comes from approved Mito Map summary fields, not raw charts or full histories. Derived means a score is calculated from existing records. Planning means a goal or estimate, not a promise.
Observed: participant totals, program counts, open opportunities, and recent update counts.
Synced summary: Mito Map sync counts plus genetics, labs, wearables, and other summary-coverage totals.
Derived: contribution scores, Research Asset Index, and trial-readiness estimates.
Planning: program goals, goal per participant, and expected active counts. These are not payouts, outcomes, or guarantees.
Not shown: raw records, individual identities, medical advice, or trial eligibility.
Current public reading rule: This page stays aggregate on purpose. If a live input is unavailable, MDA prefers a summary or planning label over pretending a clinical or enrollment number is more certain than it is.
Why transparency helps science
Clear participation makes the science easier to trust.
When people can see what is being asked and join in a clear, consented way, researchers can design better studies, compare aggregate patterns more cleanly, publish clearer reports, and return plain-language findings when results are ready.
Aggregate reporting stays separate from private records.
Study questions stay easier to review before patients spend time.
Returned findings can come back in plain language when they are ready.
Mito Map evidence
Registry depth from synced summaries.
These are aggregate counts from consented Mito Map summary fields or equivalent structured records. Raw health records are not shown publicly.
Synced summary count
Synced summary count
Synced summary count
Synced summary count
Synced summary count
Synced summary count
Derived from synced summaries
Derived from synced summaries
Counts on this section describe summary coverage only. They do not mean a study match, a trial decision, or a clinical recommendation has been made.
Disease communities
Participation by program
All Mitochondrial Disease Community
The broad Alliance community for people living with any mitochondrial disease or suspected mitochondrial condition.
Observed program count
Multi-year planning goal
Planning estimate
Synced summary count
Derived Research Asset Index
Derived from synced summaries
Derived from synced summaries
Completeness + freshness + verification
Derived from latest contribution scores
Synced summary count
Leigh Syndrome Program
An open patient partnership program for Leigh syndrome and related mitochondrial disease communities.
Observed program count
Multi-year planning goal
Planning estimate
Synced summary count
Derived Research Asset Index
Derived from synced summaries
Derived from synced summaries
Completeness + freshness + verification
Derived from latest contribution scores
Synced summary count
MELAS / m.3243A>G Program
An open patient partnership program for MELAS and m.3243A>G-related mitochondrial disease.
Observed program count
Multi-year planning goal
Planning estimate
Synced summary count
Derived Research Asset Index
Derived from synced summaries
Derived from synced summaries
Completeness + freshness + verification
Derived from latest contribution scores
Synced summary count
OPA1 Discovery Program
An open patient partnership program focused on OPA1-related mitochondrial disease.
Observed program count
Multi-year planning goal
Planning estimate
Synced summary count
Derived Research Asset Index
Derived from synced summaries
Derived from synced summaries
Completeness + freshness + verification
Derived from latest contribution scores
Synced summary count
POLG Discovery Program
A patient partnership program focused on POLG-related mitochondrial disease.
Observed program count
Multi-year planning goal
Planning estimate
Synced summary count
Derived Research Asset Index
Derived from synced summaries
Derived from synced summaries
Completeness + freshness + verification
Derived from latest contribution scores
Synced summary count
TWNK Discovery Program
An open patient partnership program focused on TWNK-related mitochondrial disease.
Observed program count
Multi-year planning goal
Planning estimate
Synced summary count
Derived Research Asset Index
Derived from synced summaries
Derived from synced summaries
Completeness + freshness + verification
Derived from latest contribution scores
Synced summary count
LHON / Mitochondrial Optic Neuropathy Program
A planning-stage patient partnership program for LHON and related mitochondrial optic neuropathy communities.
Observed program count
Multi-year planning goal
Planning estimate
Synced summary count
Derived Research Asset Index
Derived from synced summaries
Derived from synced summaries
Completeness + freshness + verification
Derived from latest contribution scores
Synced summary count
m.3243A>G Multisystem / MIDD Program
A planning-stage program for people with m.3243A>G multisystem disease, including MIDD, hearing, cardiac, renal, muscle, and neurologic manifestations beyond classic MELAS.
Observed program count
Multi-year planning goal
Planning estimate
Synced summary count
Derived Research Asset Index
Derived from synced summaries
Derived from synced summaries
Completeness + freshness + verification
Derived from latest contribution scores
Synced summary count
MERRF / m.8344A>G Program
A planning-stage program for MERRF, m.8344A>G, and related myoclonic epilepsy mitochondrial disease communities.
Observed program count
Multi-year planning goal
Planning estimate
Synced summary count
Derived Research Asset Index
Derived from synced summaries
Derived from synced summaries
Completeness + freshness + verification
Derived from latest contribution scores
Synced summary count
MT-ATP6 / NARP / Leigh Spectrum Program
A planning-stage program for MT-ATP6, NARP, and related Leigh spectrum mitochondrial disease communities.
Observed program count
Multi-year planning goal
Planning estimate
Synced summary count
Derived Research Asset Index
Derived from synced summaries
Derived from synced summaries
Completeness + freshness + verification
Derived from latest contribution scores
Synced summary count
Single Large-Scale mtDNA Deletion Program
A planning-stage program for Kearns-Sayre, CPEO/CPEO-plus, Pearson syndrome, and related single large-scale mtDNA deletion syndromes.
Observed program count
Multi-year planning goal
Planning estimate
Synced summary count
Derived Research Asset Index
Derived from synced summaries
Derived from synced summaries
Completeness + freshness + verification
Derived from latest contribution scores
Synced summary count
Open opportunities
Active ways patients can participate
Share a Leigh syndrome care update
Sponsor: Mito Discovery Alliance
15 minutes per update - 75 contribution credits
Privacy: coded or de-identified where applicable
MELAS / m.3243A>G Longitudinal Check-In
Sponsor: Mito Discovery Alliance
15 minutes monthly - 90 contribution credits
Privacy: coded or de-identified where applicable
Keep OPA1 vision and fatigue updates current
Sponsor: Mito Discovery Alliance
12 minutes to start, then periodic refresh - 60 contribution credits
Privacy: de-identified aggregate reporting
Check your POLG profile details
Sponsor: Mito Discovery Alliance
20 minutes one time - 80 contribution credits
Privacy: Alliance summary data only
Keep TWNK priorities current
Sponsor: Mito Discovery Alliance
10 minutes to start, then periodic refresh - 50 contribution credits
Privacy: de-identified aggregate reporting
Mitochondrial Natural History Readiness Study
Sponsor: TBD
15 minutes quarterly - 100 contribution credits
Privacy: coded or de-identified where applicable
For members
Your account unlocks a personal dashboard.
After joining, members can access their private dashboard at /dashboard to see program enrollment, Mito Map sync status, contribution score, MDA acknowledgements, research opportunities, impact, and patient success status.
Come back when symptoms, care, or goals change so your next summary stays current. MDA shows the aggregate progress; Mito Map keeps the detailed record.